Test Price
2,800 AED✅ Home Collection Available
FOXP2 Gene Speech-Language Disorder Type 1 Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
Clinical Accuracy & Personalised Care – Direct to Your Doorstep Within the UAE
- 99.9% Diagnostic Sensitivity – ISO 9001:2015 accredited NGS workflow (Cert: INT/EGQ/2509DA/3139) validated against international clinical standards.
- VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – Available daily from 8 AM to 11 PM, strictly adhering to UAE PDPL data privacy protocols.
- Post-Test Clinical Guidance – Complimentary telehealth result interpretation with senior genetics counsellors, aligned with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Insurance Made Simple – Direct billing verification via WhatsApp: +971 54 548 8731.
Test Overview & Methodology
This Next-Generation Sequencing (NGS) test identifies pathogenic variants in the FOXP2 gene associated with Childhood Apraxia of Speech (CAS) and related dysmorphology. Conducted on whole blood (EDTA) or an FTA card sample, the assay provides a definitive molecular diagnosis in 3–4 weeks, empowering early intervention and tailored speech therapy plans in accordance with DHA/MOHAP protocols.
| Feature | Our NGS FOXP2 Test | Closest Alternative (Sanger FOXP2 Panel) |
|---|---|---|
| Technology | NGS (Next-Generation Sequencing) | Sanger Sequencing (single exon focus) |
| Analytical Sensitivity | >99.9% (all coding regions + splice sites) | ~95% (limited to known hotspots) |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Cost (AED) | 2,800 | 3,200 – 4,500 (often requires second test) |
Physician Insight & Safety Protocols
“A pathogenic FOXP2 variant provides critical insight into the neurological basis of speech apraxia, but it must always be correlated with a thorough clinical evaluation. I guide families through the implications, ensuring that early, evidence-based speech therapy and genetic counselling are seamlessly integrated into the care plan. The goal is to support each child’s unique communication journey with precision and compassion.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory & Clinical Prerequisites
Clinical Context for Test Ordering
This genetic test is an adjunctive diagnostic tool and should not be used as a standalone screening method. A complete clinical history, family pedigree, and formal speech-language pathology assessment are required for accurate interpretation. All results are reviewed by our consultant medical geneticist.
Exclusion Criteria & Emergency Red Flags
🔴 Absolute Exclusion Criteria
- Unwillingness to provide clinical history or pedigree information (mandatory for interpretation).
- Inadequate sample volume or degradation – collection will be rescheduled at no extra cost.
- Individuals under 18 years without legal guardian consent (in compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability).
🆘 Urgent Red Flags – Seek Immediate Medical Attention
- Acute speech loss with facial droop or limb weakness (possible stroke).
- Sudden severe behavioural regression or repetitive self-injurious actions.
- Any seizure-like activity associated with speech arrest.
Patient FAQ & Clinical Guidance
1. What is the FOXP2 gene test and how will it help my child’s speech delay?
Identifying a FOXP2 mutation pinpoints a specific neurological basis for speech apraxia, allowing clinicians to personalise therapy with proven motor-speech techniques like PROMPT or DTTC. Unlike generic speech assessments, a molecular diagnosis can determine if the disorder is isolated or part of a broader syndrome, guiding early interventions that may significantly improve lifelong communication. The test is performed on a simple blood draw or a painless finger-prick FTA card.
2. Is home collection safe for genetic samples, and how do you protect my data?
Our ISO-certified phlebotomists use a completely closed, temperature-monitored cold chain system, guaranteeing sample integrity from your home to our DHA-licensed facility. All personal and genomic data are encrypted and stored under UAE’s Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), accessible only to the ordering physician and you. No third-party sharing occurs without explicit written consent.
3. What if the result is negative but my child still struggles with speech?
A negative FOXP2 result does not rule out other genetic or neurodevelopmental causes; your child’s clinical picture remains paramount, and further evaluation may be warranted. We recommend a comprehensive speech-language pathology assessment and, if indicated, a broader NGS panel for related disorders. Our genetic counsellors will explain the result in detail and support the next steps, including referral to a paediatric neurologist if dysmorphic features are present.
UAE Regulatory & Data Privacy Adherence
Data Protection & Legal Compliance
- All diagnostic data handling complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health information processing follows Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | FOXP2 Gene Speech-Language Disorder Type 1 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA) or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | F80.81 (Childhood apraxia of speech), Z13.89 (Encounter for other genetic susceptibility screening) |
| LOINC Code | 92121-8 (FOXP2 gene mutation analysis in Blood or Tissue by Molecular genetics method) |
| DHA Facility License & Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab Branding: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians